| 000 | 01804 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516041839.0 | ||
| 264 | 0 | _c20110922 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0020150 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTullai, John W | |
| 245 | 0 | 0 |
_aAP-1 is a component of the transcriptional network regulated by GSK-3 in quiescent cells. _h[electronic resource] |
| 260 |
_bPloS one _c2011 |
||
| 300 |
_ae20150 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Stability _xdrug effects |
| 650 | 0 | 4 |
_aGene Regulatory Networks _xdrug effects |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xdeficiency |
| 650 | 0 | 4 |
_aMaleimides _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 700 | 1 | _aTacheva, Silvia | |
| 700 | 1 | _aOwens, Laura J | |
| 700 | 1 | _aGraham, Julie R | |
| 700 | 1 | _aCooper, Geoffrey M | |
| 773 | 0 |
_tPloS one _gvol. 6 _gno. 5 _gp. e20150 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0020150 _zAvailable from publisher's website |
| 999 |
_c20905550 _d20905550 |
||